{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:57:59Z","timestamp":1793051879892,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,6,7]],"date-time":"2015-06-07T00:00:00Z","timestamp":1433635200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s00417-015-3068-1","type":"journal-article","created":{"date-parts":[[2015,6,6]],"date-time":"2015-06-06T01:50:57Z","timestamp":1433555457000},"page":"1537-1545","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Antifibrotic effects of pirfenidone on Tenon\u2019s fibroblasts in glaucomatous eyes: comparison with mitomycin C and 5-fluorouracil"],"prefix":"10.1007","volume":"253","author":[{"given":"Jung Hwa","family":"Na","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Rim","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin A.","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Il","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,6,7]]},"reference":[{"key":"3068_CR1","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bjo.2005.081224","volume":"90","author":"HA Quigley","year":"2006","unstructured":"Quigley HA, Broman AT (2006) The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 90:262\u2013267. doi: 10.1136\/bjo.2005.081224","journal-title":"Br J Ophthalmol"},{"key":"3068_CR2","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","volume":"120","author":"A Heijl","year":"2002","unstructured":"Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M, Early Manifest Glaucoma Trial G (2002) Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 120:1268\u20131279","journal-title":"Arch Ophthalmol"},{"key":"3068_CR3","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/archopht.120.6.701","volume":"120","author":"MA Kass","year":"2002","unstructured":"Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK 2nd, Wilson MR, Gordon MO (2002) The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 120:701\u2013713, discussion 829\u2013730","journal-title":"Arch Ophthalmol"},{"key":"3068_CR4","first-page":"3789","volume":"35","author":"DA Lee","year":"1994","unstructured":"Lee DA (1994) Antifibrosis agents and glaucoma surgery. Invest Ophthalmol Vis Sci 35:3789\u20133791","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3068_CR5","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1001\/archopht.1983.01040010795021","volume":"101","author":"EM Addicks","year":"1983","unstructured":"Addicks EM, Quigley HA, Green WR, Robin AL (1983) Histologic characteristics of filtering blebs in glaucomatous eyes. Arch Ophthalmol 101:795\u2013798","journal-title":"Arch Ophthalmol"},{"key":"3068_CR6","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1001\/archopht.1988.01060130095036","volume":"106","author":"HD Jampel","year":"1988","unstructured":"Jampel HD, McGuigan LJ, Dunkelberger GR, L'Hernault NL, Quigley HA (1988) Cellular proliferation after experimental glaucoma filtration surgery. Arch Ophthalmol 106:89\u201394","journal-title":"Arch Ophthalmol"},{"key":"3068_CR7","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1600-0420.1997.tb00484.x","volume":"224","author":"A Colotto","year":"1997","unstructured":"Colotto A, Falsini B, Cesari L, Cermola S, Iarossi G, Salgarello T, Scullica L (1997) Antimetabolites in glaucoma surgery: our experiences and results. Acta Ophthalmol Scand Suppl 224:58\u201359","journal-title":"Acta Ophthalmol Scand Suppl"},{"key":"3068_CR8","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s004170050112","volume":"236","author":"J Ren","year":"1998","unstructured":"Ren J, Shin DH, O'Grady JM, Kim YY, Juzych MS, Hughes BA, Kim C, Glover BK (1998) Long-term outcome of primary glaucoma triple procedure with adjunctive 5-fluorouracil. Graefes Arch Clin Exp Ophthalmol 236:501\u2013506","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3068_CR9","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.ophtha.2011.09.043","volume":"119","author":"J Landers","year":"2012","unstructured":"Landers J, Martin K, Sarkies N, Bourne R, Watson P (2012) A twenty-year follow-up study of trabeculectomy: risk factors and outcomes. Ophthalmology 119:694\u2013702. doi: 10.1016\/j.ophtha.2011.09.043","journal-title":"Ophthalmology"},{"key":"3068_CR10","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00061198-199808000-00004","volume":"7","author":"EE Manche","year":"1998","unstructured":"Manche EE, Afshari MA, Singh K (1998) Delayed corneal epitheliopathy after antimetabolite-augmented trabeculectomy. J Glaucoma 7:237\u2013239","journal-title":"J Glaucoma"},{"key":"3068_CR11","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0002-9394(14)71642-3","volume":"124","author":"DA Belyea","year":"1997","unstructured":"Belyea DA, Dan JA, Stamper RL, Lieberman MF, Spencer WH (1997) Late onset of sequential multifocal bleb leaks after glaucoma filtration surgery with 5-fluorouracil and mitomycin C. Am J Ophthalmol 124:40\u201345","journal-title":"Am J Ophthalmol"},{"key":"3068_CR12","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/archopht.1992.01080200029011","volume":"110","author":"HD Jampel","year":"1992","unstructured":"Jampel HD, Pasquale LR, Dibernardo C (1992) Hypotony maculopathy following trabeculectomy with mitomycin C. Arch Ophthalmol 110:1049\u20131050","journal-title":"Arch Ophthalmol"},{"key":"3068_CR13","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0002-9394(14)74481-2","volume":"114","author":"RL Stamper","year":"1992","unstructured":"Stamper RL, McMenemy MG, Lieberman MF (1992) Hypotonous maculopathy after trabeculectomy with subconjunctival 5-fluorouracil. Am J Ophthalmol 114:544\u2013553","journal-title":"Am J Ophthalmol"},{"key":"3068_CR14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000027407","volume":"213","author":"R Suzuki","year":"1999","unstructured":"Suzuki R, Nakayama M, Satoh N (1999) Three types of retinal bleeding as a complication of hypotony after trabeculectomy. Ophthalmologica 213:135\u2013138","journal-title":"Ophthalmologica"},{"key":"3068_CR15","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s004170050283","volume":"237","author":"U Schraermeyer","year":"1999","unstructured":"Schraermeyer U, Diestelhorst M, Bieker A, Theisohn M, Mietz H, Ustundag C, Joseph G, Krieglstein GK (1999) Morphologic proof of the toxicity of mitomycin C on the ciliary body in relation to different application methods. Graefes Arch Clin Exp Ophthalmol 237:593\u2013600","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3068_CR16","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3928\/1542-8877-19990201-12","volume":"30","author":"YA Akova","year":"1999","unstructured":"Akova YA, Bulut S, Dabil H, Duman S (1999) Late bleb-related endophthalmitis after trabeculectomy with mitomycin C. Ophthalmic Surg Lasers 30:146\u2013151","journal-title":"Ophthalmic Surg Lasers"},{"issue":"Pt 4","key":"3068_CR17","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/eye.1991.63","volume":"5","author":"WA Franks","year":"1991","unstructured":"Franks WA, Hitchings RA (1991) Complications of 5--fluorouracil after trabeculectomy. Eye (Lond) 5(Pt 4):385\u2013389. doi: 10.1038\/eye.1991.63","journal-title":"Eye (Lond)"},{"key":"3068_CR18","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1183\/09059180.00001111","volume":"20","author":"CJ Schaefer","year":"2011","unstructured":"Schaefer CJ, Ruhrmund DW, Pan L, Seiwert SD, Kossen K (2011) Antifibrotic activities of pirfenidone in animal models. Eur Respir Rev 20:85\u201397. doi: 10.1183\/09059180.00001111","journal-title":"Eur Respir Rev"},{"key":"3068_CR19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1183\/09059180.00000912","volume":"21","author":"L Richeldi","year":"2012","unstructured":"Richeldi L (2012) Assessing the treatment effect from multiple trials in idiopathic pulmonary fibrosis. Eur Respir Rev 21:147\u2013151. doi: 10.1183\/09059180.00000912","journal-title":"Eur Respir Rev"},{"key":"3068_CR20","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1517\/14656566.2014.867328","volume":"15","author":"A Xaubet","year":"2014","unstructured":"Xaubet A, Serrano-Mollar A, Ancochea J (2014) Pirfenidone for the treatment of idiopathic pulmonary fibrosis. Expert Opin Pharmacother 15:275\u2013281. doi: 10.1517\/14656566.2014.867328","journal-title":"Expert Opin Pharmacother"},{"key":"3068_CR21","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1345\/aph.1R337","volume":"47","author":"J Potts","year":"2013","unstructured":"Potts J, Yogaratnam D (2013) Pirfenidone: a novel agent for the treatment of idiopathic pulmonary fibrosis. Ann Pharmacother 47:361\u2013367. doi: 10.1345\/aph.1R337","journal-title":"Ann Pharmacother"},{"key":"3068_CR22","first-page":"169","volume":"18","author":"SN Giri","year":"1999","unstructured":"Giri SN, Leonard S, Shi X, Margolin SB, Vallyathan V (1999) Effects of pirfenidone on the generation of reactive oxygen species in vitro. J Environ Pathol Toxicol Oncol 18:169\u2013177","journal-title":"J Environ Pathol Toxicol Oncol"},{"key":"3068_CR23","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1167\/iovs.08-2815","volume":"50","author":"X Lin","year":"2009","unstructured":"Lin X, Yu M, Wu K, Yuan H, Zhong H (2009) Effects of pirfenidone on proliferation, migration, and collagen contraction of human Tenon's fibroblasts in vitro. Invest Ophthalmol Vis Sci 50:3763\u20133770. doi: 10.1167\/iovs.08-2815","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3068_CR24","doi-asserted-by":"crossref","first-page":"680","DOI":"10.3109\/02713683.2013.867063","volume":"39","author":"K Lee","year":"2014","unstructured":"Lee K, Young Lee S, Park SY, Yang H (2014) Antifibrotic effect of pirfenidone on human pterygium fibroblasts. Curr Eye Res 39:680\u2013685. doi: 10.3109\/02713683.2013.867063","journal-title":"Curr Eye Res"},{"key":"3068_CR25","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1167\/iovs.10-6240","volume":"52","author":"H Zhong","year":"2011","unstructured":"Zhong H, Sun G, Lin X, Wu K, Yu M (2011) Evaluation of pirfenidone as a new postoperative antiscarring agent in experimental glaucoma surgery. Invest Ophthalmol Vis Sci 52:3136\u20133142. doi: 10.1167\/iovs.10-6240","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3068_CR26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0039-6257(87)90091-9","volume":"32","author":"GL Skuta","year":"1987","unstructured":"Skuta GL, Parrish RK 2nd (1987) Wound healing in glaucoma filtering surgery. Surv Ophthalmol 32:149\u2013170","journal-title":"Surv Ophthalmol"},{"key":"3068_CR27","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1167\/iovs.03-0485","volume":"45","author":"DW Esson","year":"2004","unstructured":"Esson DW, Neelakantan A, Iyer SA, Blalock TD, Balasubramanian L, Grotendorst GR, Schultz GS, Sherwood MB (2004) Expression of connective tissue growth factor after glaucoma filtration surgery in a rabbit model. Invest Ophthalmol Vis Sci 45:485\u2013491","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3068_CR28","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.exer.2006.06.003","volume":"83","author":"K Andreev","year":"2006","unstructured":"Andreev K, Zenkel M, Kruse F, Junemann A, Schlotzer-Schrehardt U (2006) Expression of bone morphogenetic proteins (BMPs), their receptors, and activins in normal and scarred conjunctiva: role of BMP-6 and activin-A in conjunctival scarring? Exp Eye Res 83:1162\u20131170. doi: 10.1016\/j.exer.2006.06.003","journal-title":"Exp Eye Res"},{"key":"3068_CR29","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/B978-012079028-9\/50105-8","volume-title":"Asthma and COPD","author":"M Kolb","year":"2002","unstructured":"Kolb M, Xing Z, Gauldie J (2002) Growth factors. In: Barnes P, Drazen J, Rennard S, Thomson N (eds) Asthma and COPD. Academic Press, London, pp 283\u2013289"},{"key":"3068_CR30","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1042\/bj2470597","volume":"247","author":"J Varga","year":"1987","unstructured":"Varga J, Rosenbloom J, Jimenez SA (1987) Transforming growth factor beta (TGF beta) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts. Biochem J 247:597\u2013604","journal-title":"Biochem J"},{"key":"3068_CR31","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/S0021-9258(18)94267-5","volume":"264","author":"CM Overall","year":"1989","unstructured":"Overall CM, Wrana JL, Sodek J (1989) Independent regulation of collagenase, 72-kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-beta. J Biol Chem 264:1860\u20131869","journal-title":"J Biol Chem"},{"key":"3068_CR32","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1167\/iovs.05-1060","volume":"47","author":"DL Fleenor","year":"2006","unstructured":"Fleenor DL, Shepard AR, Hellberg PE, Jacobson N, Pang IH, Clark AF (2006) TGFbeta2-induced changes in human trabecular meshwork: implications for intraocular pressure. Invest Ophthalmol Vis Sci 47:226\u2013234. doi: 10.1167\/iovs.05-1060","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3068_CR33","doi-asserted-by":"crossref","first-page":"5291","DOI":"10.1167\/iovs.14-14578","volume":"55","author":"J Kuchtey","year":"2014","unstructured":"Kuchtey J, Kunkel J, Burgess LG, Parks MB, Brantley MA Jr, Kuchtey RW (2014) Elevated transforming growth factor beta1 in plasma of primary open-angle glaucoma patients. Invest Ophthalmol Vis Sci 55:5291\u20135297. doi: 10.1167\/iovs.14-14578","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3068_CR34","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1136\/bjophthalmol-2011-301132","volume":"97","author":"MA Prendes","year":"2013","unstructured":"Prendes MA, Harris A, Wirostko BM, Gerber AL, Siesky B (2013) The role of transforming growth factor beta in glaucoma and the therapeutic implications. Br J Ophthalmol 97:680\u2013686. doi: 10.1136\/bjophthalmol-2011-301132","journal-title":"Br J Ophthalmol"},{"key":"3068_CR35","doi-asserted-by":"crossref","first-page":"750459","DOI":"10.1155\/2014\/750459","volume":"2014","author":"F McDonnell","year":"2014","unstructured":"McDonnell F, O'Brien C, Wallace D (2014) The role of epigenetics in the fibrotic processes associated with glaucoma. J Ophthalmol 2014:750459. doi: 10.1155\/2014\/750459","journal-title":"J Ophthalmol"},{"key":"3068_CR36","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0039-6257(03)00038-9","volume":"48","author":"PJ Lama","year":"2003","unstructured":"Lama PJ, Fechtner RD (2003) Antifibrotics and wound healing in glaucoma surgery. Surv Ophthalmol 48:314\u2013346","journal-title":"Surv Ophthalmol"},{"key":"3068_CR37","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejps.2014.02.014","volume":"58","author":"E Conte","year":"2014","unstructured":"Conte E, Gili E, Fagone E, Fruciano M, Iemmolo M, Vancheri C (2014) Effect of pirfenidone on proliferation, TGF-beta-induced myofibroblast differentiation and fibrogenic activity of primary human lung fibroblasts. Eur J Pharm Sci 58:13\u201319. doi: 10.1016\/j.ejps.2014.02.014","journal-title":"Eur J Pharm Sci"},{"key":"3068_CR38","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1091\/mbc.12.9.2730","volume":"12","author":"B Hinz","year":"2001","unstructured":"Hinz B, Celetta G, Tomasek JJ, Gabbiani G, Chaponnier C (2001) Alpha-smooth muscle actin expression upregulates fibroblast contractile activity. Mol Biol Cell 12:2730\u20132741","journal-title":"Mol Biol Cell"},{"key":"3068_CR39","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s00417-014-2607-5","volume":"252","author":"LA Engel","year":"2014","unstructured":"Engel LA, Muether PS, Fauser S, Hueber A (2014) The effect of previous surgery and topical eye drops for primary open-angle glaucoma on cytokine expression in aqueous humor. Graefes Arch Clin Exp Ophthalmol 252:791\u2013799. doi: 10.1007\/s00417-2607-5","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3068_CR40","volume":"6","author":"Q Shi","year":"2011","unstructured":"Shi Q, Liu X, Bai Y, Cui C, Li J, Li Y, Hu S, Wei Y (2011) In vitro effects of pirfenidone on cardiac fibroblasts: proliferation, myofibroblast differentiation, migration and cytokine secretion. PLoS One 6, e28134. doi: 10.1371\/journal.pone.0028134","journal-title":"PLoS One"},{"key":"3068_CR41","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0002-9394(14)70991-2","volume":"123","author":"K Singh","year":"1997","unstructured":"Singh K, Egbert PR, Byrd S, Budenz DL, Williams AS, Decker JH, Dadzie P (1997) Trabeculectomy with intraoperative 5-fluorouracil vs mitomycin C. Am J Ophthalmol 123:48\u201353","journal-title":"Am J Ophthalmol"},{"key":"3068_CR42","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1016\/S0161-6420(00)00391-2","volume":"107","author":"K Singh","year":"2000","unstructured":"Singh K, Mehta K, Shaikh NM, Tsai JC, Moster MR, Budenz DL, Greenfield DS, Chen PP, Cohen JS, Baerveldt GS, Shaikh S (2000) Trabeculectomy with intraoperative mitomycin C versus 5-fluorouracil. Prospective randomized clinical trial. Ophthalmology 107:2305\u20132309","journal-title":"Ophthalmology"},{"key":"3068_CR43","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ophtha.2008.08.009","volume":"116","author":"AM Palanca-Capistrano","year":"2009","unstructured":"Palanca-Capistrano AM, Hall J, Cantor LB, Morgan L, Hoop J, WuDunn D (2009) Long-term outcomes of intraoperative 5-fluorouracil versus intraoperative mitomycin C in primary trabeculectomy surgery. Ophthalmology 116:185\u2013190. doi: 10.1016\/j.ophtha.2008.08.009","journal-title":"Ophthalmology"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-015-3068-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-015-3068-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-015-3068-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T11:08:16Z","timestamp":1717931296000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-015-3068-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,7]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["3068"],"URL":"https:\/\/doi.org\/10.1007\/s00417-015-3068-1","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,7]]}}}